Tomomichi Iida

Urinary A- and C-megalin predict progression of diabetic kidney disease: a retrospective cohort study

N. Kitamura, I. Narita, Keiko Kabasawa, 2021 .

Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.

N. Kitamura, I. Narita, M. Hosojima, 2022, Journal of diabetes and its complications.

Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.

I. Narita, H. Kagamu, T. Kikuchi, 2017, Journal of the American Society of Nephrology : JASN.

Exocytosis-Mediated Urinary Full-Length Megalin Excretion Is Linked With the Pathogenesis of Diabetic Nephropathy

T. Ochiya, I. Narita, Y. Yoshioka, 2017, Diabetes.

Assessing fluid volume and determining outcomes of acute heart failure using plasma human atrial natriuretic peptide

S. Goto, I. Narita, Suguru Yamamoto, 2023, Clinical and Experimental Nephrology.

Megalin is involved in angiotensinogen-induced, angiotensin II-mediated ERK1/2 signaling to activate Na+-H+ exchanger 3 in proximal tubules

K. Tsumoto, S. Nagatoishi, A. Saito, 2023, Journal of hypertension.